Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Atherosclerotic Parkinsonism

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Atherosclerotic Parkinsonism in 4 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, KX1
Bergstrom, DA1
Ruskin, DN1
Walters, JR1
Marin, C1
Tolosa, E1
Wachtel, H2
Kunow, M2
Löschmann, PA2
Lange, KW1
Rettig, KJ1
Jähnig, P1
Honoré, T1
Turski, L1
Jenner, P1
Marsden, CD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Namenda as Prevention for Post-Operative Delirium[NCT00303433]Phase 430 participants Interventional2006-03-31Terminated
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Atherosclerotic Parkinsonism

ArticleYear
N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Synapse (New York, N.Y.), 1998, Volume: 30, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum;

1998
Glutamate receptor-mediated mechanisms in levodopa-induced motor fluctuations in an experimental model of parkinsonism.
    Advances in neurology, 1999, Volume: 80

    Topics: Animals; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Levodopa; Male; Parkinson Dise

1999
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
    Neuroscience letters, 1992, Aug-17, Volume: 142, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Apomorphine; Dopamin

1992
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease.
    Journal of neural transmission. Parkinson's disease and dementia section, 1991, Volume: 3, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Ac

1991